Liposomal tacrolimus and intestinal drug concentration

Transplantation Proceedings

Volumn 30, Issue 6, 1998, Pages 2651-2652

  Dutta, S ^a   Mezei, M ^a   Lee, T D G ^a   McAlister, V C ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; LIPOSOME; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISPOSITION; DRUG FORMULATION; DRUG TISSUE LEVEL; FEMALE; GRAFT SURVIVAL; INTESTINE ABSORPTION; INTESTINE TRANSPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; INTESTINE, SMALL; KIDNEY; LIPOSOMES; LIVER; METABOLIC CLEARANCE RATE; MICE; SPLEEN; TACROLIMUS; TISSUE DISTRIBUTION;

EID: 0031688063     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00774-X     Document Type: Conference Paper

References (3)

1. McAlister VC, Grant DR: In Grant DR, Wood RFM (eds): Small Bowel Transplantation. Edward Arnold; London: 1994, p 121
2. Smeesters C, Giroux L, Vinet B, et al: Cana J Surg 31:34, 1988
3. Ko S, Nakajima Y, Kanehiro H, et al: Transplantation 59:1384, 1995